Bimzelx 160 mg solution for injection in pre-filled pen

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire De Nice, UCB Biopharma

Conditions

Axial spondyloarthritisHidradenitis suppurativaModerate to Severe Plaque PsoriasisPsoriatic arthritispsoriasis

Phase 1

A multicenter, open-label, prospective study to assess the concentration of bimekizumab in mature breast milk from mothers receiving treatment with Bimzelx® (bimekizumab)

Not yet recruitingCTIS2024-518689-29-00

UCB BiopharmaAxial spondyloarthritis, Hidradenitis suppurativa, Moderate to Severe Plaque Psoriasis +1

Target: 8Updated: 2025-07-07

Phase 2

EARLYPSO Early intervention in plaque psoriasis: is bimekizumab able to delay chronic inflammation? Prospective multicenter interventional study

RecruitingCTIS2024-514647-29-01

Centre Hospitalier Universitaire De Nicepsoriasis

Start: 2025-07-22Target: 40Updated: 2025-09-05